Clinical evidence supports the concept that there are advantage in controlling blood pressure (BP). However, these comparative clinical trials have not assessed dietracial differences in response to antihypertensive drugs. The high frequency of dietary salt sensitivity and ary salt consumption, the salt sensitivity status of the participants, nor have they explored full titration doslow plasma renin activity (PRA) in hypertensives of African-American descent has been suggested by some ages of the comparative drugs. For these reasons, there is insufficient information to state with certainty whether to be the critical factor which explains this difference. Evaluation of the antihypertensive response of Africansome drugs may be more effective than others as monotherapy in controlling BP in hypertensives of AfricanAmericans to diuretics and calcium channel blockers compared to other drugs suggest that they may have an American descent.
Introduction
vated renin-angiotensin (RA) system. However, a Hypertensive disease in African-Americans is contrary view may be that the excessive intrarenal characterized by hemodynamic and biochemical vasoconstriction observed in African-American factors that are somewhat different than those seen hypertensives may, in part, be related to overactivity in Caucasian populations. [1] [2] These patients tend to of the intrarenal RA system. Consequently, reversing be younger and have greater problems with the angiotensin II-mediated intrarenal vasoconstriction frequency and intensity of hypertension and are may be an optimal way to lower blood pressure (BP) frequently poorly controlled. 3 Side effects may be a through enhancing salt and water excretion by the problem particularly in males and target organ damkidney. age occurs much earlier in the disease process and Prior clinical studies have demonstrated that there is a somewhat different treatment efficacy proAfrican-Americans do not respond well to betafile. 4 Hypertensives of African-American descent blockers or ACE inhibitors as do their non-black more frequently exhibit salt-sensitivity and a varihypertensive counterparts. 11, 12 Some have suggested able tendency toward expanded plasma volume, that this difference is related to the fact that these lower plasma renin activity (PRA), and increased therapies have proven to be more effective in peripheral and renal vascular resistance. 1, 2, 5, 6 Biopatients who have higher PRA and less of a tendchemically, African-Americans have reduced natriency toward expanded plasma volume. 13 However, uretic and vasodilatory substances such as dopamcontroversy in this regard persists in the literature ine, prostaglandins, and kinins compared to due to the fact that higher doses of ACE inhibitors Caucasians. 7, 8 Additionally, studies of ion transport do facilitate BP reduction in African-American in red blood cells demonstrate different sodiumhypertensives, 14, 15 and no clinical studies have potassium and sodium-lithium counter transport explored full dose titration of ACE inhibitors or between African-Americans and Caucasians which beta-blockers in patients whose dietary salt intake may explain, in part, their tendency towards salt has been assessed, or have been previously profiled and water retention by the kidneys and expanded as being salt-sensitive or not. Moreover, chronic plasma volume. 9, 10 dosing of ACE inhibitors eliminates much of the preThese latter pathophysiologic features suggest that dictive value of renin profiling in predicting the optimal strategies to control hypertensive disease in antihypertensive response to these drugs.
16,17
African-Americans should be focused on modest dietary salt restriction and pharmacologic therapy, Salt sensitivity and the kidney which enhances salt and water excretion as opposed
The kidney may play a primary role in the development of BP salt sensitivity. This may occur through 
Salt-sensitivity and the renin angiotensin system
Since the RA system is an important determinant of efferent glomerular arteriole tone and its activity is modulated by both dietary salt ingestion and systemic BP, it is likely that it also plays an important role in the diminished pressure natriuresis response observed in salt-sensitive hypertensives. Inadequate suppression of the RA system in response to greater dietary salt ingestion may result in greater intrarenal vasoconstriction, particularly at the efferent glomerular arteriole which could result in greater glomerular filtration fraction and intraglomerular hypertension, and systemic hypertension due to salt and water retention. 24 A correlation has been observed between the lack of dietary salt-induced suppression of PRA and diminished renal plasma flow and increased glomerular filtration fraction in both normotensive and hypertensive subjects, 20 which supports these theories. Since most patients effects of ACE inhibition were as great in salt-sensiThese observations suggest that impaired natriuresis tive patients as in salt-insensitive patients. These in salt-sensitive hypertensives is in part related to studies are an important contribution to our underan incapacity of the kidney to increase renal blood standing about the RA system as they refute the flow in response to greater dietary salt ingestion.
hypothesis that salt sensitivity is a low renin volume Additionally, an increase in glomerular filtration expanded state which would have minimal response fraction could also enhance salt and water retention to inhibition of angiotensin II effect. More by the kidney through a reduction in peritubular importantly, their work suggests that suppressing capillary (post-glomerular) hydrostatic pressure and angiotensin II formation restores the pressure natrian increase in peritubular capillary oncotic pressuresis response in these patients. ure.
23
Assessing what pharmacologic effects of the ACE inhibitor induces renal vasodilation is complex since ACE inhibitors can reduce vascular tone not only through blocking angiotensin II formation, but also through decreasing bradykinin degradation or increasing prostaglandin and nitric oxide formation.
27 Clinical trials using renin inhibitors which have no effect on kinin or prostaglandin production, demonstrate enhanced renal vasodilatory responses in both normotensive and salt-sensitive hypertensives. 20 These observations strongly support the concept that angiotensin II plays a critical role in the impaired renal hemodynamic response to increasing dietary salt and suggests that the ability of the ACE inhibitor to block angiotensin II formation explains an important part of their beneficial effects on the kidney and BP in salt-sensitive patients. Conse- tive populations such as African-Americans. Such American descent and Caucasians. We compared the effects of placebo 1, 2, and 4 mg/day of trandolapril in 207 Caucasians and 91 African-American hypertensive patients utilizing a double-blind, randomized, parallel study design.
14 After 6 weeks of double-blind treatment, we observed that AfricanAmerican hypertensive patients required approximately 2-4 times the dose of an ACE inhibitor as similar age-and sex-matched Caucasian hypertensive patients for similar diastolic (DBP) and systolic BP (SBP) readings to be achieved. Moreover, in the Caucasian hypertensive patients, reductions in BP correlated with serum ACE inhibition at these lower doses, whereas, in the lower renin, presumably more salt-sensitive African-American hypertensive patients, despite similar reduction in serum ACE activity, BP reduction did not occur until higher doses of trandolapril were employed (4 mg) ( Figure  5 ). Thus, there was dissociation between serum ACE inhibition and the antihypertensive activity of the trandolapril in the African-American hyperten- doses of ACE inhibitors, or could indicate that the ACE inhibitor has another property which is responsible for BP reduction independent of serum ACE studies in salt-sensitive patients may demonstrate activity in lower renin patients. Interestingly, we differences between ACE inhibitors with regard to also observed a reduction in serum aldosterone contheir ability to reduce BP which could be related to centration 14 ( Figure 6 ), which occurred with higher how they bind and adhere to ACE in the tissues, doses of trandolapril in the African-American particularly in vascular beds in the kidney. There hypertensives which could be important to facilitate also may be differential dose requirements of ACE BP reduction, particularly in this population which inhibitors to affect BP changes vs renal hemodynis frequently salt-sensitive, with a low PRA and amic changes which may be particularly important tendency toward volume expansion. 1, 2 in facilitating BP control in salt-sensitive popuIn subsequent clinical studies we explored the lations.
utility of higher doses of trandolapril (ranging from 0.25 mg/day to 16 mg/day) in 505 Caucasians and Recent comparative clinical trials of ACE 322 African-American patients with mild-to-moderinhibitors in African-American and Caucasian ate hypertension. 28,29 Following 6 weeks of doublehypertensives blind treatment, it was evident that African-American patients at lower doses (0.25-4 mg) required We have recently conducted clinical trials with a 64-twice as much trandolapril in order to achieve simifold dosing range of a new non-sulfhydryl ACE inhibitor, trandolapril, in hypertensives of Africanlar BP reduction as observed in Caucasians. How- Figure 6 These bar graphs illustrate changes in serum aldosterone and plasma renin levels from baseline to end-point after 6 weeks of therapy for Caucasian (˿) and African-American () hypertensive patients. Data is expressed as mean ± s.e.m. to salt-sensitivity on varying dietary salt consumption when treated with either diuretics, calcium channel blockers or ACE inhibitors. This would ever, above doses of 4 mg/day the differences between the two races narrowed significantly. When improve our understanding about the utilization of these drugs in different demographic populations. evaluating dosing by weight on a mg/kg/day dosing basis, there were only subtle differences between the It is quite clear from existing clinical data that patients with low PRA and dietary salt sensitivity two races with both populations starting to respond at .0175 mg/kg per day. 28 There were no racial differhave an impaired pressure natriuresis response, perhaps related to diminished increase in renal plasma ences in antihypertensive response to trandalopril based on pretreatment renin activity being low (less flow and an increase in glomerular filtration fraction that occurs in response to greater dietary salt ingesthan 0.7 ng/ml/hr) or normal (0.7 to 3.0 ng/mg/hr). 29 We also observed that decreases in serum ACE tion. [20] [21] [22] One particular pathway which may be important in attenuating this pathophysiologic activity in response to a given trandolapril dose were similar in both racial groups. 28 These data sugresponse is to block the effect of angiotensin II within the kidney. As discussed in this review, it is gest that pretreatment PRA does not predict the antihypertensive response to ACE inhibitors when apparent that ACE inhibitors and renin inhibitors are capable of improving the pressure natriuresis dosed chronically in either Caucasian 16, 17 or African-American populations. 28, 29 Additionally, response to increasing dietary salt in both nonmodulators and salt-sensitive patients. [19] [20] [21] [22] 25, 26 It is these results suggest that ACE inhibitors may need to be dosed by weight and that some of the apparent also apparent that higher doses of ACE inhibitors can improve BP control in patients such as Africanineffectiveness of ACE inhibitors in African-American hypertensives may be related to a lower dose Americans with low PRA. 14, 28, 29 This effect is unrelated to blocking serum ACE 14 and might be related per bodyweight ratio.
to either inhibiting plasma aldosterone production or attenuating intrarenal vasoconstriction. The latter
Conclusions
effects may result from greater inhibition of ACE within the tissues as opposed to the serum or other Future clinical investigation is necessary to assess the role of dietary salt restriction as an adjunct to pathways could be responsible for the antihypertensive effects of these drugs, particularly when higher pharmacologic therapy, particularly in salt-sensitive hypertensives. It would be particularly interesting to doses are employed. Thus, population character- 
